COGT
Price
$12.30
Change
-$0.19 (-1.52%)
Updated
Jul 21 closing price
Capitalization
1.71B
21 days until earnings call
IMMX
Price
$2.99
Change
+$0.02 (+0.67%)
Updated
Jul 21 closing price
Capitalization
83.35M
43 days until earnings call
Interact to see
Advertisement

COGT vs IMMX

Header iconCOGT vs IMMX Comparison
Open Charts COGT vs IMMXBanner chart's image
Cogent Biosciences
Price$12.30
Change-$0.19 (-1.52%)
Volume$2.03M
Capitalization1.71B
Immix Biopharma
Price$2.99
Change+$0.02 (+0.67%)
Volume$306.45K
Capitalization83.35M
COGT vs IMMX Comparison Chart in %
Loading...
COGT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
IMMX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
COGT vs. IMMX commentary
Jul 22, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is COGT is a StrongBuy and IMMX is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 22, 2025
Stock price -- (COGT: $12.30 vs. IMMX: $2.99)
Brand notoriety: COGT and IMMX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: COGT: 60% vs. IMMX: 122%
Market capitalization -- COGT: $1.71B vs. IMMX: $83.35M
COGT [@Biotechnology] is valued at $1.71B. IMMX’s [@Biotechnology] market capitalization is $83.35M. The market cap for tickers in the [@Biotechnology] industry ranges from $286.69B to $0. The average market capitalization across the [@Biotechnology] industry is $2.43B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

COGT’s FA Score shows that 0 FA rating(s) are green whileIMMX’s FA Score has 0 green FA rating(s).

  • COGT’s FA Score: 0 green, 5 red.
  • IMMX’s FA Score: 0 green, 5 red.
According to our system of comparison, COGT is a better buy in the long-term than IMMX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

COGT’s TA Score shows that 4 TA indicator(s) are bullish while IMMX’s TA Score has 4 bullish TA indicator(s).

  • COGT’s TA Score: 4 bullish, 3 bearish.
  • IMMX’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, COGT is a better buy in the short-term than IMMX.

Price Growth

COGT (@Biotechnology) experienced а +10.91% price change this week, while IMMX (@Biotechnology) price change was +3.46% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +6.05%. For the same industry, the average monthly price growth was +18.19%, and the average quarterly price growth was +35.70%.

Reported Earning Dates

COGT is expected to report earnings on Aug 12, 2025.

IMMX is expected to report earnings on Sep 03, 2025.

Industries' Descriptions

@Biotechnology (+6.05% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
COGT($1.72B) has a higher market cap than IMMX($83.4M). COGT YTD gains are higher at: 57.692 vs. IMMX (35.909). IMMX has higher annual earnings (EBITDA): -21.62M vs. COGT (-284.04M). COGT has more cash in the bank: 246M vs. IMMX (15.9M). IMMX has less debt than COGT: IMMX (1.06M) vs COGT (17.1M). COGT (0) and IMMX (0) have equivalent revenues.
COGTIMMXCOGT / IMMX
Capitalization1.72B83.4M2,056%
EBITDA-284.04M-21.62M1,314%
Gain YTD57.69235.909161%
P/E RatioN/AN/A-
Revenue00-
Total Cash246M15.9M1,547%
Total Debt17.1M1.06M1,615%
FUNDAMENTALS RATINGS
COGT: Fundamental Ratings
COGT
OUTLOOK RATING
1..100
30
VALUATION
overvalued / fair valued / undervalued
1..100
84
Overvalued
PROFIT vs RISK RATING
1..100
49
SMR RATING
1..100
99
PRICE GROWTH RATING
1..100
92
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
COGTIMMX
RSI
ODDS (%)
Bearish Trend 1 day ago
88%
Bearish Trend 1 day ago
90%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
90%
Momentum
ODDS (%)
Bullish Trend 1 day ago
88%
Bullish Trend 1 day ago
78%
MACD
ODDS (%)
Bullish Trend 1 day ago
86%
Bullish Trend 1 day ago
90%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
84%
Bullish Trend 1 day ago
87%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
83%
Bullish Trend 1 day ago
87%
Advances
ODDS (%)
Bullish Trend 5 days ago
83%
Bullish Trend 1 day ago
84%
Declines
ODDS (%)
N/A
Bearish Trend 12 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
90%
Aroon
ODDS (%)
Bullish Trend 1 day ago
77%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
COGT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
IMMX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
PIIRX15.900.09
+0.57%
Putnam International Value R
BTMPX17.990.08
+0.45%
iShares MSCI EAFE Intl Idx Inv P
RYNVX160.060.33
+0.21%
Rydex Nova Inv
DDVIX14.030.02
+0.14%
Macquarie Value Inst
JNDVX12.64-0.01
-0.08%
Janus Henderson U.S. Dividend Income N

COGT and

Correlation & Price change

A.I.dvisor indicates that over the last year, COGT has been loosely correlated with HOFBF. These tickers have moved in lockstep 63% of the time. This A.I.-generated data suggests there is some statistical probability that if COGT jumps, then HOFBF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To COGT
1D Price
Change %
COGT100%
-1.52%
HOFBF - COGT
63%
Loosely correlated
N/A
TNFA - COGT
55%
Loosely correlated
+47.89%
CRNX - COGT
52%
Loosely correlated
-0.51%
ATXS - COGT
50%
Loosely correlated
+4.86%
IDYA - COGT
49%
Loosely correlated
+1.02%
More

IMMX and

Correlation & Price change

A.I.dvisor indicates that over the last year, IMMX has been loosely correlated with IMTX. These tickers have moved in lockstep 36% of the time. This A.I.-generated data suggests there is some statistical probability that if IMMX jumps, then IMTX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IMMX
1D Price
Change %
IMMX100%
+0.67%
IMTX - IMMX
36%
Loosely correlated
-2.50%
XERS - IMMX
36%
Loosely correlated
+0.59%
COGT - IMMX
33%
Poorly correlated
-1.52%
CRNX - IMMX
32%
Poorly correlated
-0.51%
ERAS - IMMX
32%
Poorly correlated
N/A
More